Skip to main content
Erschienen in: Supportive Care in Cancer 1/2022

10.08.2021 | Original Article

Clinical utility of oral management in allogeneic hematopoietic stem cell transplantation recipients: microbiological evidence based on molecular analysis of oral bacteria

verfasst von: Jumpei Kawajiri, Kokoro Nagata, Akiko Nakamura, Atsushi Fujieda, Kazuko Ino, Jouji Nomura, Naoya Arai, Kohshi Ohishi, Naoyuki Katayama, Kazunori Nakase

Erschienen in: Supportive Care in Cancer | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to clarify the clinical utility of oral management to prevent bloodstream infections by oral bacteria microbiologically in patients undergoing allogeneic hematopoietic stem cell transplantation (ASCT).

Methods

Ten consecutive patients with hematological malignancies undergoing ASCT were enrolled in this study. We implemented dental treatments before transplantation, if required, and carried out oral hygiene instructions and oral management every other day after transplantation. Molecular analysis of bacterial DNA for seven oral species using a polymerase chain reaction (PCR) assay was performed for oral samples and peripheral blood once a week for 3 weeks after transplantation.

Results

Periodontitis was found in all 10 patients (mild grade in 3 and middle grade in 7) for whom basic periodontal therapy was conducted. Necessary dental procedures, including tooth extraction were performed in 5 patients. After transplantation, oral mucositis occurred in 10 patients (grade 1 in 3, grade 2 in 2, and grade 3 in 5) for whom oral hygiene instruction and oral care were continued every other day. PCR-identified three to six bacterial species in oral samples from nine patients, but none in peripheral blood from any patient during the observation period.

Conclusions

Our study suggests that oral management could prevent bloodstream infections by oral bacteria in ASCT recipients despite the existence of periodontitis or oral mucositis. Its utility was confirmed by microbiological evidence based on molecular data.
Literatur
1.
Zurück zum Zitat Raber-Durlacher JE, Laheij AMGA, Epstein JB, Epstein M, Geerligs GM, Wolffe GN, Blijlevens NMA, Peter Donnelly J (2013) Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer 21(6):1621–1627. https://doi.org/10.1007/s00520-012-1706-2CrossRefPubMed Raber-Durlacher JE, Laheij AMGA, Epstein JB, Epstein M, Geerligs GM, Wolffe GN, Blijlevens NMA, Peter Donnelly J (2013) Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study. Support Care Cancer 21(6):1621–1627. https://​doi.​org/​10.​1007/​s00520-012-1706-2CrossRefPubMed
3.
Zurück zum Zitat M Haverman, J E Raber-Durlacher, W M H Rademacher, S Vokurka, J B Epstein, C Huisman, M D Hazenberg, J J de Soet, J de Lange, F R Rozema (2014) Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators of Inflammation 2014. https://doi.org/10.1155/2014/378281 M Haverman, J E Raber-Durlacher, W M H Rademacher, S Vokurka, J B Epstein, C Huisman, M D Hazenberg, J J de Soet, J de Lange, F R Rozema (2014) Oral complications in hematopoietic stem cell recipients: the role of inflammation. Mediators of Inflammation 2014. https://​doi.​org/​10.​1155/​2014/​378281
5.
Zurück zum Zitat Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S (2009) Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Support Care Cancer 17(5):581–587. https://doi.org/10.1007/s00520-008-0532-zCrossRefPubMed Soga Y, Yamasuji Y, Kudo C, Matsuura-Yoshimoto K, Yamabe K, Sugiura Y, Maeda Y, Ishimaru F, Tanimoto M, Nishimura F, Takashiba S (2009) Febrile neutropenia and periodontitis: lessons from a case periodontal treatment in the intervals between chemotherapy cycles for leukemia reduced febrile neutropenia. Support Care Cancer 17(5):581–587. https://​doi.​org/​10.​1007/​s00520-008-0532-zCrossRefPubMed
8.
Zurück zum Zitat Sugawara Y, Nakase K, Nakamura A, Ohishi K, Sugimoto Y, Fujieda A, Monma F, Suzuki K, Masuya M, Matsushima Y, Wada H, Nobori T, Katayama N (2013) Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Heematol 90(4):331–339. https://doi.org/10.1111/ejh.12078CrossRef Sugawara Y, Nakase K, Nakamura A, Ohishi K, Sugimoto Y, Fujieda A, Monma F, Suzuki K, Masuya M, Matsushima Y, Wada H, Nobori T, Katayama N (2013) Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders. Eur J Heematol 90(4):331–339. https://​doi.​org/​10.​1111/​ejh.​12078CrossRef
14.
Zurück zum Zitat Atsushi Fujieda, Kazunori Nakase, Akiko Nakamura, Kohshi Ohishi, Yuka Sugimoto, Fumihiko Monma, Masahiro Masuya, Naoyuki Katayama (2019) Clinical utility of molecular diagnosis of blood stream infections in allogeneic hematopoietic stem cell transplantation recipients with hematologic malignancies. Advances in Microbiology: 9(12). https://doi.org/10.4236/aim.2019.912062 Atsushi Fujieda, Kazunori Nakase, Akiko Nakamura, Kohshi Ohishi, Yuka Sugimoto, Fumihiko Monma, Masahiro Masuya, Naoyuki Katayama (2019) Clinical utility of molecular diagnosis of blood stream infections in allogeneic hematopoietic stem cell transplantation recipients with hematologic malignancies. Advances in Microbiology: 9(12). https://​doi.​org/​10.​4236/​aim.​2019.​912062
18.
Zurück zum Zitat Antunes H-S, de Sá E-M, Ferreira L-M-D, de Faria M, Schirmer P-C, Small I-A, Colares M, Bouzas L-F-D, Ferreira C-G (2010) Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal 15(2):303–309. https://doi.org/10.4317/medoral.15.e303CrossRef Antunes H-S, de Sá E-M, Ferreira L-M-D, de Faria M, Schirmer P-C, Small I-A, Colares M, Bouzas L-F-D, Ferreira C-G (2010) Streptococcal bacteraemia in patients submitted to hematopoietic stem cell transplantation: the role of tooth brushing and use of chlorhexidine. Med Oral Patol Oral Cir Bucal 15(2):303–309. https://​doi.​org/​10.​4317/​medoral.​15.​e303CrossRef
Metadaten
Titel
Clinical utility of oral management in allogeneic hematopoietic stem cell transplantation recipients: microbiological evidence based on molecular analysis of oral bacteria
verfasst von
Jumpei Kawajiri
Kokoro Nagata
Akiko Nakamura
Atsushi Fujieda
Kazuko Ino
Jouji Nomura
Naoya Arai
Kohshi Ohishi
Naoyuki Katayama
Kazunori Nakase
Publikationsdatum
10.08.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 1/2022
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-021-06462-9

Weitere Artikel der Ausgabe 1/2022

Supportive Care in Cancer 1/2022 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.